1 Harris WS (2007) Omega-3 fatty acids and cardiovascular disease: a case for omega-3 index as a new risk factor. Pharmacol Res 55, 217–223.
2 Panagiotakos DB, Pitsavos C, Zampelas A, et al. (2005) Fish consumption and the risk of developing acute coronary syndromes: the CARDIO2000 study. Int J Cardiol 105, 403–409.
3 Iso H, Kobayashi M, Ishihara J, et al. (2006) Intake of fish and n-3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based (JPHC) Study Cohort I. Circulation 113, 195–202.
4 Li Q, Wang M, Tan L, et al. (2005) Docosahexaenoic acid changes lipid composition and interleukin-2 receptor signaling in membrane rafts. J Lipid Res 46, 1904–1913.
5 Calder PC (2006) n-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 83, 1505S–1519S.
6 Thies F, Garry JM, Yaqoob P, et al. (2003) Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet 361, 477–485.
7 Geleijnse JM, Giltay EJ, Grobbee DE, et al. (2002) Blood pressure response to fish oil supplementation: metaregression analysis of randomised trials. J Hypertens 20, 1493–1499.
8 Goodfellow J, Bellamy MF, Ramsey MW, et al. (2000) Dietary supplementation with marine omega-3 fatty acids improves systemic large artery endothelial function in subjects with hypercholesterolemia. J Am Coll Cardiol 35, 265–270.
9 Harris WS (1997) n-3 Fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 65, 1645–1654.
10 Mori TA, Bao DQ, Burke V, et al. (1999) Dietary fish as a major component of a weight-loss diet: effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects. Am J Clin Nutr 70, 817–825.
11 Harris WS & Bulchandani D (2006) Why do omega-3 fatty acids lower serum triacylglycerols? Curr Opin Lipidol 17, 387–393.
12 Wallace TM & Matthews DR (2002) The assessment of insulin resistance in man. Diabet Med 19, 527–534.
13 Colditz GA, Manson JE, Stampfer MJ, et al. (1992) Diet and risk of clinical diabetes in women. Am J Clin Nutr 55, 1018–1023.
14 Feskens EJM, Loeber JG & Kromhout D (1994) Diet and physical activity as determinants of hyperinsulinemia: The Zutphen Elderly Study. Am J Epidemiol 140, 350–360.
15 Borkman M, Chisholm DJ, Furler SM, et al. (1989) Effects of fish oil supplementation on glucose and lipid metabolism in NIDDM. Diabetes 38, 1314–1319.
16 Vessby B, Uusitupa M, Hermansen K, et al. (2001) Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: the KANWU study. Diabetologia 44, 312–319.
17 Delarue J, LeFoll C, Corporeau C, et al. (2004) n-3 Long chain polyunsaturated fatty acids: a nutritional tool to prevent insulin resistance associated to type 2 diabetes and obesity? Reprod Nutr Dev 44, 289–299.
18 Delarue J, Couet C, Cohen R, et al. (1996) Effects of fish oil on metabolic responses to oral fructose and glucose loads in healthy humans. Am J Physiol 270, 353–362.
19 Stene LC, Ulriksen J, Magnus P, et al. (2000) Use of cod liver oil during pregnancy associated with lower risk of type I diabetes in the offspring. Diabetologia 43, 1093–1098.
20 Facchini F & Saylor KL (2002) Effect of iron depletion on cardiovascular risk factors. Studies in carbohydrate-intolerant patients. Ann N Y Acad Sci 967, 342–351.
21 Hua NW, Stoohs RA & Facchini F (2001) Low iron status and enhanced insulin sensitivity in lacto-ovo vegetarians. Br J Nutr 86, 515–519.
22 Moher D, Schultz KF & Altman DG (2001) The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 357, 1191–1194.
23 Friedewald WT, Levy RI & Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18, 499–502.
24 Navas-Carretero S, Pérez-Granados AM, Sarriá B, et al. (2008) Oily fish increases iron bioavailability of a phytate rich meal in young iron deficient women. J Am Coll Nutr 27, 96–101.
25 Navas-Carretero S, Sarriá B, Pérez-Granados AM, et al. (2006) . In Bioavailability 2006. Optimizing Dietary Strategies for Better Health in Developing Countries, p. 148 [Kalambaheti Y and Charoenkiatkul S, editors]. Chiang Mai: Mahidol University.
27 Aranceta J & Serra-Majem L (2001) . In Guías alimentarias para la población española, pp. 183–194. Madrid: Sociedad Española de Nutrición Comunitaria, IM&C.
28 British Nutrition Foundation (1992) Unsaturated Fatty Acids: Nutritional and Physiological Significance: The Report of the British Nutrition Foundation's Task Force. London: Chapman & Hall.
30 FAO/WHO (1998) Fats and Oils in Human Nutrition. Report of a Joint FAO/WHO Expert Consultation. FAO Food and Nutrition Paper no. 57. Rome: Food and Agriculture Organization of the United Nations.
31 Ros E (2001) . In Guías alimentarias para la población española, pp. 413–421. Madrid: Sociedad Española de Nutrición Comunitaria, IM&C.
32 Finnegan YE, Minihane AM, Leigh-Firbank EC, et al. (2003) Plant- and marine-derived n-3 polyunsaturated fatty acids have differential effects on fasting and postprandial blood lipid concentrations and on the susceptibility of LDL to oxidative modification in moderately hyperlipidemic subjects. Am J Clin Nutr 77, 783–795.
33 Kris-Etherton PM, Harris WS & Appel LJ (2002) Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106, 2747–2757.
34 Rice R (1988) Fish oils – their significance to human health. J R Soc Med 81, 499–501.
35 Pedersen H, Petersen M, Major-Pedersen A, et al. (2003) Influence of fish oil supplementation on in vivo and in vitro oxidation resistance of low-density lipoprotein in type 2 diabetes. Eur J Clin Nutr 57, 713–720.
36 Lapointe A, Couillard C & Lemieux S (2006) Effects of dietary factors on oxidation of low-density lipoprotein particles. J Nutr Biochem 17, 645–658.
37 Higgins S, Carroll YL, McCarthy SN, et al. (2001) Susceptibility of LDL to oxidative modification in healthy volunteers supplemented with low doses of n-3 polyunsaturated fatty acids. Br J Nutr 85, 23–31.
38 Turini ME, Crozier GL, Donnet-Hughes A, et al. (2001) Short-term fish oil supplementation improved innate inmunity, but increased ex vivo oxidation of LDL in man – a pilot study. Eur J Nutr 40, 56–65.
39 Lee YS & Wander RC (2005) Reduced effect on apoptosis of 4-hydroxyhexenal and oxidized LDL enriched with n-3 fatty acids from postmenopausal women. J Nutr Biochem 16, 213–221.
40 Miles EA, Thies F, Wallace FA, et al. (2001) Influence of age and dietary fish oil on plasma soluble adhesion molecule concentrations. Clin Sci 100, 91–100.
41 Schoppen S, Pérez-Granados AM, Carbajal A, et al. (2004) A sodium-rich bicarbonated mineral water reduces cardiovascular risk in postmenopausal women. J Nutr 134, 1058–1063.
42 Covas MI (2007) Olive oil and the cardiovascular system. Pharmacol Res 55, 175–186.
43 Martín de Santa Olalla L, Sánchez-Muniz FJ & Vaquero MP (2009) n-3 Fatty acids in glucose metabolism and insulin sensitivity. Nutr Hosp 24, .
44 Browning LM, Krebs JK, Moore CS, et al. (2007) The impact of long chain n-3 polyunsaturated fatty acid supplementation on inflammation, insulin sensitivity and CVD risk in a group of overweight women with an inflammatory phenotype. Diabetes Obes Metab 9, 70–80.
45 Griffin MD, Sanders T, Davies IG, et al. (2006) Effects of altering the ratio of dietary n-6 to n-3 fatty acids on insulin sensitivity, lipoprotein size, and postprandial lipemia in men and postmenopausal women aged 45–70 y: the OPTILIP Study. Am J Clin Nutr 84, 1290–1298.
46 Abete I, Parra D, Crujeiras AB, et al. (2008) Specific insulin sensitivity and leptin responses to a nutritional treatment of obesity via a combination of energy restriction and fatty fish intake. J Hum Nutr Diet 21, 591–600.
47 Ramel A, Martinez A, Kiely M, et al. (2008) Beneficial effects of long-chain n-3 fatty acids included in an energy-restricted diet on insulin resistance in overweight and obese European young adults. Diabetologia 51, 1261–1268.
48 Nugent C, Prins JB, Whitehead JP, et al. (2001) Arachidonic acid stimulates glucose uptake in 3T3-L1 adipocytes by increasing GLUT1 and GLUT4 levels at the plasma membrane. Evidence for involvement of lipoxygenase metabolites and peroxisome proliferator-activated receptor gamma. J Biol Chem 276, 9149–9157.
49 Paniagua JA, Gallego de la Sacristana A, Sánchez E, et al. (2007) A MUFA-rich diet improves posprandial glucose, lipid and GLP-1 responses in insulin-resistant subjects. J Am Coll Nutr 26, 434–444.
50 Vessby B, Tengblad S & Lithell H (1994) Insulin sensitivity is related to the fatty acid composition of serum lipids and skeletal muscle phospholipids in 70-year-old men. Diabetologia 37, 1044–1050.
51 Storlien LH, Jenkins AB, Chisholm DJ, et al. (1991) Influence of dietary fat composition on development of insulin resistance in rats. Relationships to muscle triglyceride and omega-3 fatty acids in muscle phospholipid. Diabetes 40, 280–289.
52 Jacobs DR & Steffen LM (2003) Nutrients, foods, and dietary patterns as exposures in research: a framework for food synergy. Am J Clin Nutr 78, 508S–513S.
53 Mittra S, Bansal VS & Bhatnagar PK (2008) From a glucocentric to a lipocentric approach towards metabolic syndrome. Drug Discov Today 13, 211–218.